Literature DB >> 3900143

IgG enzyme linked immunosorbent assay for diagnosis of invasive aspergillosis: retrospective study over 15 years of transplant recipients.

A K Trull, J Parker, R E Warren.   

Abstract

Four commercially available Aspergillus fumigatus antigens were compared in an IgG enzyme linked immunosorbent assay by testing multiple sera from 19 patients who had received renal and hepatic allografts and who had histologically confirmed invasive aspergillosis. Raised antibody levels were found in 16 of the 19 patients. More antibody responses were detected by culture filtrate antigens, but somatic antigens often detected antibodies sooner. When antibodies to Aspergillus antigens were present before transplantation the onset of fatal disseminated infection was earlier. Antibody levels often fell to within the normal range, even in cases of fulminant disseminated infection. Repeated serology was essential for detection of an antibody response.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3900143      PMCID: PMC499356          DOI: 10.1136/jcp.38.9.1045

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  9 in total

1.  Aspergillus infection complicating cardiac transplantation. Report of five cases.

Authors:  M J Gurwith; E B Stinson; J S Remington
Journal:  Arch Intern Med       Date:  1971-10

2.  Efficacy of enzyme-linked immunosorbent assay in serodiagnosis of aspergillosis.

Authors:  S K Mishra; S Falkenberg; K N Masihi
Journal:  J Clin Microbiol       Date:  1983-04       Impact factor: 5.948

Review 3.  Invasive aspergillosis.

Authors:  M G Rinaldi
Journal:  Rev Infect Dis       Date:  1983 Nov-Dec

4.  Diagnosis of invasive aspergillosis by passive hemagglutination assay of antibody.

Authors:  J W Gold; B Fisher; B Yu; N Chein; D Armstrong
Journal:  J Infect Dis       Date:  1980-07       Impact factor: 5.226

5.  Serologic immunodiagnosis of of invasive aspergillosis.

Authors:  K Holmberg; M Berdischewsky; L S Young
Journal:  J Infect Dis       Date:  1980-05       Impact factor: 5.226

6.  Invasive aspergillosis. Absence of detectable antibody response.

Authors:  R C Young; J E Bennett
Journal:  Am Rev Respir Dis       Date:  1971-11

7.  A solid-phase radioimmunoassay for the measurement of antibody to Aspergillus in invasive aspergillosis.

Authors:  R Marier; W Smith; M Jansen; V T Andriole
Journal:  J Infect Dis       Date:  1979-11       Impact factor: 5.226

8.  An aspergillus immunodiffusion test in the early diagnosis of aspergillosis in adult leukemia patients.

Authors:  J C Schaefer; B Yu; D Armstrong
Journal:  Am Rev Respir Dis       Date:  1976-03

9.  Use of the immunodiffusion test in the serodiagnosis of aspergillosis.

Authors:  R M Coleman; L Kaufman
Journal:  Appl Microbiol       Date:  1972-02
  9 in total
  6 in total

1.  10 year review of invasive aspergillosis detected at necropsy.

Authors:  A P Boon; D O'Brien; D H Adams
Journal:  J Clin Pathol       Date:  1991-06       Impact factor: 3.411

2.  Cerebral aspergillosis in liver transplantation.

Authors:  A P Boon; D H Adams; J Buckels; P McMaster
Journal:  J Clin Pathol       Date:  1990-02       Impact factor: 3.411

Review 3.  Serological techniques for diagnosis of fungal infection.

Authors:  L de Repentigny
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-04       Impact factor: 3.267

Review 4.  Aspergillosis.

Authors:  G P Bodey; S Vartivarian
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-05       Impact factor: 3.267

5.  Guidelines for the investigation of invasive fungal infections in haematological malignancy and solid organ transplantation. British Society for Medical Mycology.

Authors:  D W Denning; E G Evans; C C Kibbler; M D Richardson; M M Roberts; T R Rogers; D W Warnock; R E Warren
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-06       Impact factor: 3.267

Review 6.  New developments in the diagnosis of opportunistic fungal infection.

Authors:  V Hopwood; D W Warnock
Journal:  Eur J Clin Microbiol       Date:  1986-08       Impact factor: 3.267

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.